Clinical trials
Stroke trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 4 |
| 2013 | 4 |
| 2014 | 6 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 2 |
| 2022 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Unknown status | 9 |
| Recruiting | 7 |
| Active, not recruiting | 5 |
| Terminated | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 5 |
| Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 5 |
| National Cerebral and Cardiovascular Center, Japan | 4 |
| Novartis Pharmaceuticals | 3 |
| Astellas Pharma Inc | 2 |
| Bayer | 2 |
| GlaxoSmithKline | 2 |
| Insel Gruppe AG, University Hospital Bern | 2 |
| Pfizer | 2 |
| Tanabe Pharma Corporation | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stroke | 67 |
| Ischemic Stroke | 18 |
| Atrial Fibrillation | 15 |
| Myocardial Infarction | 9 |
| Brain Ischemia | 6 |
| Cardiovascular Diseases | 6 |
| Cerebrovascular Disorders | 5 |
| Coronary Artery Disease | 5 |
| Heart Diseases | 5 |
| Heart Failure | 4 |
Trials
Showing 26 to 50 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.